Stay updated on Daratumumab in PGNMID and C3 GN Clinical Trial
Sign up to get notified when there's something new on the Daratumumab in PGNMID and C3 GN Clinical Trial page.

Latest updates to the Daratumumab in PGNMID and C3 GN Clinical Trial page
- Check4 days agoNo Change Detected
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedAdded: a note that publications are automatically filled from PubMed and may not be about the study, and a new revision tag (v3.3.2); removed the older PubMed-origin text and the earlier revision tag (v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedRemoved a general government funding status notice from the page. The notice previously informed users about potential delays and updates due to funding and operating status of NIH facilities.SummaryDifference0.4%

- Check34 days agoChange DetectedThe new version shows minor UI and formatting updates with no changes to the study's core details (eligibility, outcomes, dosing, or locations).SummaryDifference0.4%

- Check63 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference4%

- Check70 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

- Check84 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; removed the Back to Top element. No other substantive content changes.SummaryDifference0.3%

Stay in the know with updates to Daratumumab in PGNMID and C3 GN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab in PGNMID and C3 GN Clinical Trial page.